Second-line pharmacologic therapies, which have proven efficacy in helping patients to quit but do not have an FDA indication for smoking cessation and have undesirable side effects compared to first-line agents, include clonidine (Catapres) and nortriptyline (Pamelor;Aventyl), both available by oral administration
Many hospitalaffiliated outpatient programs can also coordinate care, injections, lab work, and insurance navigation
We also offer custom options to tailor every detail of your product to your specifications
three others remain in effect, and two run through 2030
This temporary phase shouldnt cause alarm
Depression Motivates Quit Attempts but Predicts Relapse: Differential Findings for Gender from the International Tobacco Control Study